Tobii is the world leader in eye tracking – a technology that allows a computer to tell exactly where a person is looking. Eye tracking is used in a broad range of applications including market research and eye controlled computer interfaces. Headquartered in Stockholm Tobii covers the global market with offices in USA, China, Japan, Norway, UK and South Korea. If you want to work with meaningful products and solve interesting problems, we might be the right company for you!
Tobii China成立于2008年底,经过多年的发展,瑞典总部不断调整中国公司的战略地位,从单纯的以生产为主的制造型企业,到2012年底,正式转变为以研发、销售为主,辅以物流,制造,售后维修,成为亚太地区的战略中心,并在北京、深圳、广州、台北多地派驻销售技术人员。
中国公司不断适应总部提出的新要求,并为员工打造轻松人性化的工作氛围和具有瑞典文化气息的企业文化,并为员工提供更多的创造和挑战机会。如果您喜欢稳定自由和谐的工作环境,如果您喜欢高科技自主研发公司,如果您想参与人类前沿科技的发展,那么我们公司将是您的理想选择。
EyeSee is a tech-enabled consumer research partner, providing highly predictive insights for shopper, advertising, innovation, and e-commerce optimization. Equipped with cross-category knowledge, our team is 150+ multidisciplinary experts strong and driven by passion to understand and help businesses grow. Join the ranks of top-tier CPG companies, healthcare innovators, and media trailblazers who trust EyeSee's proven formula to navigate today's complex market dynamics with confidence.
Three pillars of our research approach:
1. Comprehensive Insights: We employ a sophisticated mix-method approach, blending implicit and explicit methodologies to deliver 360-degree insights with high predictive power.
2. Realistic Testing Environments: Harnessing the prowess of our agile in-house design teams, we create lifelike virtual simulations of stores, social media platforms, and e-commerce sites. These simulated environments enable us to capture the subtlest and most authentic consumer behaviors.
3. Personalized Guidance: Our dedicated insights experts serve as your strategic partners, synthesizing data into actionable recommendations that drive tangible results.
With our award-winning framework as the backbone, we lead studies spanning 50+ countries, stationed strategically in key hubs like New York, London, Paris, Antwerp, Mexico City, Belgrade, and Singapore. Among our most sought-after solutions are tests designed for packaging, planograms, claims, social media ads, TV commercials (TVCs), and e-commerce websites.
Understand behavior, grow further!
"iMotions is now a Smart Eye company. In October 2021 Smart Eye acquired iMotions. iMotions continues to be independently-run, while the combined companies are working to create the first powerhouse for analyzing emotional, cognitive and behavioral data, delivering holistic human insights."
The iMotions software helps unpack human behavior by combining multiple biosensor data to uncover underlying emotions and responses.
The platform enables research in market studies, academics, healthcare, UX, automotive, advertisement, education, and more. iMotions is used worldwide by leading universities such as Harvard, Yale, MIT, and Stanford as well as corporations such as gsk, P&G, Unilever, BMW, and Duracell.
iMotions integrates best-in-class biosensors and synchronizes Eye Tracking, Facial Expression Analysis, EEG, EDA/GSR, EMG, ECG and Surveys in one unified software platform.
iMotions continuously develop its product to be the most comprehensive, easy to use and scalable biometric research platform in the market. It helps our clients conduct state-of-the-art human behavior research in the areas of Psychology, Neuroscience, Human Factors Engineering, Education, Health, Business, and Human Computer Interaction.
iMotions is a high tech software development company originally founded in 2005, headquartered in Copenhagen, Denmark with offices in the USA, Germany, and Singapore.
Read more on https://imotions.com
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.